CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

FHS
May 6, 2024
5:03 pm

Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

New pharma CEOs in the hot seat

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

February 8, 2024

United Therapeutics sues FDA over handling of Liquidia’s NDA – Pharmaceutical Technology

Share this article Tyvaso has entered blockbuster territory, seeing global sales of $1.2bn in 2023, up 41% from 2022 sales. Image credit: Shutterstock/viewimage. United Therapeutics

February 22, 2024

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.